Clinical trial
Risk Factors for Venous Thromboembolism in the Community
NCT00011180 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00011180 |
|---|---|
| Title | Risk Factors for Venous Thromboembolism in the Community |
| Official title | Subtherapeutic Heparin Anticoagulation as a Predictor of Recurrent Venous Thromboembolism: A Population-Based Cohort Study |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Thromboembolism |
| Enrollment | 385 |
| Start date | Apr 1, 2001 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Feb 13, 2001 |
| Last update posted | Dec 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: